140 related articles for article (PubMed ID: 3450293)
1. Polarographic studies on the conformation of some platinum complexes: relations to anti-tumour activity.
Vrána O; Brabec V; Kleinwächter V
Anticancer Drug Des; 1986 Apr; 1(2):95-109. PubMed ID: 3450293
[TBL] [Abstract][Full Text] [Related]
2. Reaction of platinum cytostatics of the second generation with deoxyribonucleic acid.
Kleinwächter V; Rau H
Drugs Exp Clin Res; 1986; 12(6-7):523-5. PubMed ID: 3743370
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and DNA conformational changes of non-covalent polynuclear platinum complexes.
Qu Y; Harris A; Hegmans A; Petz A; Kabolizadeh P; Penazova H; Farrell N
J Inorg Biochem; 2004 Oct; 98(10):1591-8. PubMed ID: 15458821
[TBL] [Abstract][Full Text] [Related]
4. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
[TBL] [Abstract][Full Text] [Related]
5. The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA.
Zaludová R; Natile G; Brabec V
Anticancer Drug Des; 1997 Jun; 12(4):295-309. PubMed ID: 9199661
[TBL] [Abstract][Full Text] [Related]
6. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of DNA complexation with antitumor therapeutic cis-DDP and binuclear bivalent platinum compound containing pyrazine].
Kas'ianenko NA; Aĭa EE; Bogdanov AA; Kosmotynskaia IuV; Iakovlev KI
Mol Biol (Mosk); 2002; 36(4):745-52. PubMed ID: 12173482
[TBL] [Abstract][Full Text] [Related]
8. The effect of combined treatment with platinum complexes and ionizing radiation on DNA in vitro.
Vrána O; Brabec V
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Dec; 50(6):995-1007. PubMed ID: 3491805
[TBL] [Abstract][Full Text] [Related]
9. The interaction of DNA-targeted platinum phenanthridinium complexes with DNA in human cells.
Whittaker J; McFadyen WD; Baguley BC; Murray V
Anticancer Drug Des; 2001; 16(2-3):81-9. PubMed ID: 11962516
[TBL] [Abstract][Full Text] [Related]
10. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
Kasparkova J; Vojtiskova M; Natile G; Brabec V
Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
Knox RJ; Friedlos F; Lydall DA; Roberts JJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
[TBL] [Abstract][Full Text] [Related]
12. Osmium-induced alteration in DNA structure.
Lukásová E; Vojtísková M; Jelen F; Sticzay T; Palecek E
Gen Physiol Biophys; 1984 Apr; 3(2):175-91. PubMed ID: 6537362
[TBL] [Abstract][Full Text] [Related]
13. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
Gay M; Montaña AM; Moreno V; Prieto MJ; Pérez JM; Alonso C
Bioorg Med Chem; 2006 Mar; 14(5):1565-72. PubMed ID: 16256352
[TBL] [Abstract][Full Text] [Related]
14. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
15. Different binding to DNA of enantiomeric platinum complexes assessed by inhibition of restriction enzyme activity.
Coluccia M; Giordano D; Loseto F; Intini FP; Maresca L; Natile G
Anticancer Res; 1989; 9(3):795-8. PubMed ID: 2548438
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient DNA compaction mediated by an in vivo antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
Yoshikawa Y; Komeda S; Uemura M; Kanbe T; Chikuma M; Yoshikawa K; Imanaka T
Inorg Chem; 2011 Nov; 50(22):11729-35. PubMed ID: 22004345
[TBL] [Abstract][Full Text] [Related]
17. Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.
Kasparkova J; Vrana O; Farrell N; Brabec V
J Inorg Biochem; 2004 Oct; 98(10):1560-9. PubMed ID: 15458817
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of palladium(II) and platinum(II) complexes with Schiff bases derivatives of 2-pyridincarboxyaldehyde. Study of their interaction with DNA.
García-Friaza G; Fernández-Botello A; Pérez JM; Prieto MJ; Moreno V
J Inorg Biochem; 2006 Aug; 100(8):1368-77. PubMed ID: 16712937
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, DNA binding and cytotoxicity of isohelical DNA groove binding platinum complexes.
Wheate NJ; Webster LK; Brodie CR; Collins JG
Anticancer Drug Des; 2000 Oct; 15(5):313-22. PubMed ID: 11354307
[TBL] [Abstract][Full Text] [Related]
20. Intercalation into the DNA double helix and in vivo biological activity of water-soluble planar [Pt(diimine)(N,N-dihydroxyethyl-N'-benzoylthioureato)]+Cl- complexes: a study of their thermal stability, their CD spectra and their gel mobility.
Wu YS; Koch KR; Abratt VR; Klump HH
Arch Biochem Biophys; 2005 Aug; 440(1):28-37. PubMed ID: 16009327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]